152 related articles for article (PubMed ID: 22981725)
21. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
22. Α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation.
Wang Y; Xia Z; Xu JR; Wang YX; Hou LN; Qiu Y; Chen HZ
Neuropharmacology; 2012 Feb; 62(2):871-81. PubMed ID: 21958557
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding.
Milton NG; Harris JR
Micron; 2009 Dec; 40(8):800-10. PubMed ID: 19683452
[TBL] [Abstract][Full Text] [Related]
24. Substituted tryptophans at amyloid-β(1-40) residues 19 and 20 experience different environments after fibril formation.
McDonough RT; Paranjape G; Gallazzi F; Nichols MR
Arch Biochem Biophys; 2011 Oct; 514(1-2):27-32. PubMed ID: 21843498
[TBL] [Abstract][Full Text] [Related]
25. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
26. Aβ42 oligomers, but not fibrils, simultaneously bind to and cause damage to ganglioside-containing lipid membranes.
Williams TL; Johnson BR; Urbanc B; Jenkins AT; Connell SD; Serpell LC
Biochem J; 2011 Oct; 439(1):67-77. PubMed ID: 21702743
[TBL] [Abstract][Full Text] [Related]
27. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
28. Bexarotene Does Not Clear Amyloid Beta Plaques but Delays Fibril Growth: Molecular Mechanisms.
Huy PDQ; Thai NQ; Bednarikova Z; Phuc LH; Linh HQ; Gazova Z; Li MS
ACS Chem Neurosci; 2017 Sep; 8(9):1960-1969. PubMed ID: 28689412
[TBL] [Abstract][Full Text] [Related]
29. Novel method for quantitative determination of amyloid fibrils of alpha-synuclein and amyloid beta/A4 protein by using resveratrol.
Ahn JS; Lee JH; Kim JH; Paik SR
Anal Biochem; 2007 Aug; 367(2):259-65. PubMed ID: 17597573
[TBL] [Abstract][Full Text] [Related]
30. Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide.
Sheikh AM; Nagai A
FEBS J; 2011 Feb; 278(4):634-42. PubMed ID: 21205198
[TBL] [Abstract][Full Text] [Related]
31. Hsp20, a novel alpha-crystallin, prevents Abeta fibril formation and toxicity.
Lee S; Carson K; Rice-Ficht A; Good T
Protein Sci; 2005 Mar; 14(3):593-601. PubMed ID: 15722443
[TBL] [Abstract][Full Text] [Related]
32. Secreted amyloid precursor protein and holo-APP bind amyloid beta through distinct domains eliciting different toxic responses on hippocampal neurons.
Kedikian G; Heredia F; Salvador VR; Raimunda D; Isoardi N; Heredia L; Lorenzo A
J Neurosci Res; 2010 Jun; 88(8):1795-803. PubMed ID: 20155808
[TBL] [Abstract][Full Text] [Related]
33. Ca(2+) enhances Aβ polymerization rate and fibrillar stability in a dynamic manner.
Brännström K; Ohman A; Lindhagen-Persson M; Olofsson A
Biochem J; 2013 Feb; 450(1):189-97. PubMed ID: 23171033
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory activity of stilbenes on Alzheimer's beta-amyloid fibrils in vitro.
Rivière C; Richard T; Quentin L; Krisa S; Mérillon JM; Monti JP
Bioorg Med Chem; 2007 Jan; 15(2):1160-7. PubMed ID: 17049256
[TBL] [Abstract][Full Text] [Related]
35. Determining binding sites of polycyclic aromatic small molecule-based amyloid-beta peptide aggregation modulators using sequence-specific antibodies.
Irwin JA; Edward Wong H; Kwon I
Anal Biochem; 2015 Feb; 470():61-70. PubMed ID: 25449301
[TBL] [Abstract][Full Text] [Related]
36. Sugar-based peptidomimetics inhibit amyloid β-peptide aggregation.
Dorgeret B; Khemtémourian L; Correia I; Soulier JL; Lequin O; Ongeri S
Eur J Med Chem; 2011 Dec; 46(12):5959-69. PubMed ID: 22027101
[TBL] [Abstract][Full Text] [Related]
37. Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction.
Yan Y; Liu Y; Sorci M; Belfort G; Lustbader JW; Yan SS; Wang C
Biochemistry; 2007 Feb; 46(7):1724-31. PubMed ID: 17253767
[TBL] [Abstract][Full Text] [Related]
38. Binding of proteases to fibrillar amyloid-beta protein and its inhibition by Congo red.
Chander H; Chauhan A; Chauhan V
J Alzheimers Dis; 2007 Nov; 12(3):261-9. PubMed ID: 18057560
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
[TBL] [Abstract][Full Text] [Related]
40. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
Hou L; Zagorski MG
J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
